Dirk Schadendorf
迪尔克·沙登多夫
MD
Director, Department of Dermatology; Chairman, Skin Cancer Center皮肤科主任，皮肤癌中心主席
👥Biography 个人简介
Dirk Schadendorf is Germany's preeminent melanoma specialist and chairs the Essen Skin Cancer Center. His contributions span melanoma biology, targeted therapy, immunotherapy combinations, and long-term survival analysis, and he has led or contributed to numerous pivotal international melanoma trials.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Long-Term Survival with Ipilimumab
Led pooled long-term survival analysis of over 1800 ipilimumab-treated melanoma patients, establishing the landmark plateau in the survival curve indicating durable long-term benefit in a subset.
Targeted and Immunotherapy Combinations
Contributed to pivotal trials combining BRAF/MEK inhibitors with checkpoint blockade, evaluating sequencing and combination strategies to maximize antitumor immunity.
Melanoma Biomarker Development
Identified and validated serum and tumor tissue biomarkers including LDH, S100B, and molecular signatures for predicting prognosis and guiding treatment selection in melanoma.
Representative Works 代表性著作
Pooled Analysis of Long-Term Survival Data from Phase II and III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
Journal of Clinical Oncology (2015)
Definitive analysis demonstrating long-term survival plateau with ipilimumab, fundamentally changing the view of melanoma as incurable.
Pembrolizumab versus Ipilimumab for Advanced Melanoma: Final Overall Survival Analysis of KEYNOTE-006
Journal of Clinical Oncology (2021)
Long-term OS data confirming durable survival benefit of pembrolizumab over ipilimumab in advanced melanoma.
Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma (CheckMate 067): 6.5-Year Outcomes
Journal of Clinical Oncology (2022)
Extended follow-up confirming durable survival advantage of dual checkpoint blockade over ipilimumab monotherapy.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
University of California, Los Angeles
Caroline Robert
Institut Gustave Roussy
Paolo Antonio Ascierto
Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples
Reinhard Dummer
University Hospital Zurich
关注 迪尔克·沙登多夫 的研究动态
Follow Dirk Schadendorf's research updates
留下邮箱，当我们发布与 Dirk Schadendorf（University Hospital Essen）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment